3 Stocks Pushing The Health Services Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading up 33 points (0.2%) at 16,455 as of Friday, March 7, 2014, 12:00 PM ET. The NYSE advances/declines ratio sits at 1,158 issues advancing vs. 1,766 declining with 168 unchanged.

The Health Services industry currently sits down 0.4% versus the S&P 500, which is unchanged. On the negative front, top decliners within the industry include Smith & Nephew ( SNN), down 1.8%, Agilent Technologies ( A), down 1.5% and St Jude Medical ( STJ), down 1.1%. Top gainers within the industry include Opko Health ( OPK), up 2.9%, DENTSPLY International ( XRAY), up 1.5% and Grifols ( GRFS), up 0.8%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Waters Corporation ( WAT) is one of the companies pushing the Health Services industry lower today. As of noon trading, Waters Corporation is down $0.71 (-0.6%) to $112.07 on light volume. Thus far, 105,862 shares of Waters Corporation exchanged hands as compared to its average daily volume of 586,700 shares. The stock has ranged in price between $111.83-$113.65 after having opened the day at $113.23 as compared to the previous trading day's close of $112.78.

Waters Corporation operates as an analytical instrument manufacturer in the United States and internationally. Waters Corporation has a market cap of $9.6 billion and is part of the technology sector. Shares are up 12.9% year-to-date as of the close of trading on Thursday. Currently there are 4 analysts that rate Waters Corporation a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Waters Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Waters Corporation Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Zimmer Holdings ( ZMH) is down $0.49 (-0.5%) to $97.76 on average volume. Thus far, 465,810 shares of Zimmer Holdings exchanged hands as compared to its average daily volume of 1.1 million shares. The stock has ranged in price between $97.32-$98.75 after having opened the day at $98.56 as compared to the previous trading day's close of $98.25.

Zimmer Holdings, Inc., through its subsidiaries, engages in the design, development, manufacture, and marketing of orthopedic reconstructive devices, spinal and trauma devices, biologics, dental implants, and related surgical products in the Americas, Europe, and the Asia Pacific. Zimmer Holdings has a market cap of $16.4 billion and is part of the health care sector. Shares are up 0.8% year-to-date as of the close of trading on Thursday. Currently there are 10 analysts that rate Zimmer Holdings a buy, 1 analyst rates it a sell, and 11 rate it a hold.

TheStreet Ratings rates Zimmer Holdings as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, solid stock price performance and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Zimmer Holdings Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Humana ( HUM) is down $0.97 (-0.9%) to $110.50 on average volume. Thus far, 780,527 shares of Humana exchanged hands as compared to its average daily volume of 1.7 million shares. The stock has ranged in price between $109.84-$111.23 after having opened the day at $111.23 as compared to the previous trading day's close of $111.47.

Humana Inc., a health care company, offers a range of insurance products, and health and wellness services that incorporate an integrated approach to lifelong well-being. The company operates in Retail, Employer Group, Healthcare Services, and Other Businesses segments. Humana has a market cap of $17.2 billion and is part of the health care sector. Shares are up 8.5% year-to-date as of the close of trading on Thursday. Currently there are 13 analysts that rate Humana a buy, 1 analyst rates it a sell, and 8 rate it a hold.

TheStreet Ratings rates Humana as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Humana Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Purdue Pharma Unloads Sales Staff, Transitioning From Painkiller Focus

Purdue Pharma Unloads Sales Staff, Transitioning From Painkiller Focus

Dow Finishes Lower as Nasdaq Posts New Record

Dow Finishes Lower as Nasdaq Posts New Record

Airlines Rebuke Trump Policy of Separating Children

Airlines Rebuke Trump Policy of Separating Children